Copyright 2019 Hubbard Radio Washington DC, LLC. All rights reserved. This website is not intended for users located within the European Economic Area.
FDA approves 9 generic versions of nerve pain drug Lyrica
TRENTON, N.J. (AP) — The U.S. Food and Drug Administration has approved the first generic copies of a popular, pricey pill for nerve pain.
The agency on Monday said it approved nine generic versions of Pfizer Inc.’s Lyrica. It is also used for seizures and fibromyalgia, a condition that causes chronic, widespread pain.
Lyrica, approved in 2004, is Pfizer’s second bestseller, with sales last year of $4.6 billion. The heavily advertised drug costs about $460 to $720 per month without insurance, depending on the pharmacy. Prices can vary widely.
Prices for generic versions range from about $140 to $370 per month, according to the drug price comparison site GoodRx .
Advertisement
Common side effects include dizziness, blurred vision and sleepiness. Serious side effects include allergic reactions and life-threatening breathing problems.
Copyright © 2019 The Associated Press. All rights reserved. This website is not intended for users located within the European Economic Area.
Top Stories
-
Congress catches up on security clearance modernization efforts in NDAA Top Story -
Defense bill puts brakes on Pentagon plan to reduce uniformed medical jobs Defense -
Fearing ‘cyber 9/11,’ national security council stresses unified emergency response from agencies Cybersecurity -
DoD will used SOCOM, TRANSCOM as pathfinders for JEDI Defense -
The ‘as-a-service model’ is starting to take hold as agencies move beyond the cloud Views from the Corner Office
The Associated Press
Government Events
